Copyright Reports & Markets. All rights reserved.

Global Phytohemagglutinin M(PHA-M) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Phytohemagglutinin M(PHA-M) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 98% Purity
    • 1.3.3 99% Purity
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Phytohemagglutinin M(PHA-M) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Research
    • 1.4.3 Medicine
    • 1.4.4 Other
  • 1.5 Global Phytohemagglutinin M(PHA-M) Market Size & Forecast
    • 1.5.1 Global Phytohemagglutinin M(PHA-M) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Phytohemagglutinin M(PHA-M) Sales Quantity (2020-2031)
    • 1.5.3 Global Phytohemagglutinin M(PHA-M) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Capricorn Scientific
    • 2.1.1 Capricorn Scientific Details
    • 2.1.2 Capricorn Scientific Major Business
    • 2.1.3 Capricorn Scientific Phytohemagglutinin M(PHA-M) Product and Services
    • 2.1.4 Capricorn Scientific Phytohemagglutinin M(PHA-M) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Capricorn Scientific Recent Developments/Updates
  • 2.2 Sartorius
    • 2.2.1 Sartorius Details
    • 2.2.2 Sartorius Major Business
    • 2.2.3 Sartorius Phytohemagglutinin M(PHA-M) Product and Services
    • 2.2.4 Sartorius Phytohemagglutinin M(PHA-M) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Sartorius Recent Developments/Updates
  • 2.3 Biowest
    • 2.3.1 Biowest Details
    • 2.3.2 Biowest Major Business
    • 2.3.3 Biowest Phytohemagglutinin M(PHA-M) Product and Services
    • 2.3.4 Biowest Phytohemagglutinin M(PHA-M) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Biowest Recent Developments/Updates
  • 2.4 Cellseco
    • 2.4.1 Cellseco Details
    • 2.4.2 Cellseco Major Business
    • 2.4.3 Cellseco Phytohemagglutinin M(PHA-M) Product and Services
    • 2.4.4 Cellseco Phytohemagglutinin M(PHA-M) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Cellseco Recent Developments/Updates
  • 2.5 Biosera
    • 2.5.1 Biosera Details
    • 2.5.2 Biosera Major Business
    • 2.5.3 Biosera Phytohemagglutinin M(PHA-M) Product and Services
    • 2.5.4 Biosera Phytohemagglutinin M(PHA-M) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Biosera Recent Developments/Updates

3 Competitive Environment: Phytohemagglutinin M(PHA-M) by Manufacturer

  • 3.1 Global Phytohemagglutinin M(PHA-M) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Phytohemagglutinin M(PHA-M) Revenue by Manufacturer (2020-2025)
  • 3.3 Global Phytohemagglutinin M(PHA-M) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Phytohemagglutinin M(PHA-M) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Phytohemagglutinin M(PHA-M) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Phytohemagglutinin M(PHA-M) Manufacturer Market Share in 2024
  • 3.5 Phytohemagglutinin M(PHA-M) Market: Overall Company Footprint Analysis
    • 3.5.1 Phytohemagglutinin M(PHA-M) Market: Region Footprint
    • 3.5.2 Phytohemagglutinin M(PHA-M) Market: Company Product Type Footprint
    • 3.5.3 Phytohemagglutinin M(PHA-M) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Phytohemagglutinin M(PHA-M) Market Size by Region
    • 4.1.1 Global Phytohemagglutinin M(PHA-M) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Phytohemagglutinin M(PHA-M) Consumption Value by Region (2020-2031)
    • 4.1.3 Global Phytohemagglutinin M(PHA-M) Average Price by Region (2020-2031)
  • 4.2 North America Phytohemagglutinin M(PHA-M) Consumption Value (2020-2031)
  • 4.3 Europe Phytohemagglutinin M(PHA-M) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Phytohemagglutinin M(PHA-M) Consumption Value (2020-2031)
  • 4.5 South America Phytohemagglutinin M(PHA-M) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Phytohemagglutinin M(PHA-M) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Phytohemagglutinin M(PHA-M) Sales Quantity by Type (2020-2031)
  • 5.2 Global Phytohemagglutinin M(PHA-M) Consumption Value by Type (2020-2031)
  • 5.3 Global Phytohemagglutinin M(PHA-M) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Phytohemagglutinin M(PHA-M) Sales Quantity by Application (2020-2031)
  • 6.2 Global Phytohemagglutinin M(PHA-M) Consumption Value by Application (2020-2031)
  • 6.3 Global Phytohemagglutinin M(PHA-M) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Phytohemagglutinin M(PHA-M) Sales Quantity by Type (2020-2031)
  • 7.2 North America Phytohemagglutinin M(PHA-M) Sales Quantity by Application (2020-2031)
  • 7.3 North America Phytohemagglutinin M(PHA-M) Market Size by Country
    • 7.3.1 North America Phytohemagglutinin M(PHA-M) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Phytohemagglutinin M(PHA-M) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Phytohemagglutinin M(PHA-M) Sales Quantity by Type (2020-2031)
  • 8.2 Europe Phytohemagglutinin M(PHA-M) Sales Quantity by Application (2020-2031)
  • 8.3 Europe Phytohemagglutinin M(PHA-M) Market Size by Country
    • 8.3.1 Europe Phytohemagglutinin M(PHA-M) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Phytohemagglutinin M(PHA-M) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Phytohemagglutinin M(PHA-M) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Phytohemagglutinin M(PHA-M) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Phytohemagglutinin M(PHA-M) Market Size by Region
    • 9.3.1 Asia-Pacific Phytohemagglutinin M(PHA-M) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Phytohemagglutinin M(PHA-M) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Phytohemagglutinin M(PHA-M) Sales Quantity by Type (2020-2031)
  • 10.2 South America Phytohemagglutinin M(PHA-M) Sales Quantity by Application (2020-2031)
  • 10.3 South America Phytohemagglutinin M(PHA-M) Market Size by Country
    • 10.3.1 South America Phytohemagglutinin M(PHA-M) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Phytohemagglutinin M(PHA-M) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Phytohemagglutinin M(PHA-M) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Phytohemagglutinin M(PHA-M) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Phytohemagglutinin M(PHA-M) Market Size by Country
    • 11.3.1 Middle East & Africa Phytohemagglutinin M(PHA-M) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Phytohemagglutinin M(PHA-M) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Phytohemagglutinin M(PHA-M) Market Drivers
  • 12.2 Phytohemagglutinin M(PHA-M) Market Restraints
  • 12.3 Phytohemagglutinin M(PHA-M) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Phytohemagglutinin M(PHA-M) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Phytohemagglutinin M(PHA-M)
  • 13.3 Phytohemagglutinin M(PHA-M) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Phytohemagglutinin M(PHA-M) Typical Distributors
  • 14.3 Phytohemagglutinin M(PHA-M) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Phytohemagglutinin M(PHA-M) market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    ‌Phytohemagglutinin M (referred to as PHA-M)‌ is a lectin extracted from leguminous plants. It belongs to the high molecular glycoproteins and is a complex of oligosaccharides and proteins. PHA-M has the activity of promoting mitosis and inducing interferon secretion, and is often used in immunological research and clinical applications‌.
    This report is a detailed and comprehensive analysis for global Phytohemagglutinin M(PHA-M) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Phytohemagglutinin M(PHA-M) market size and forecasts, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/mL), 2020-2031
    Global Phytohemagglutinin M(PHA-M) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/mL), 2020-2031
    Global Phytohemagglutinin M(PHA-M) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/mL), 2020-2031
    Global Phytohemagglutinin M(PHA-M) market shares of main players, shipments in revenue ($ Million), sales quantity (L), and ASP (US$/mL), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Phytohemagglutinin M(PHA-M)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Phytohemagglutinin M(PHA-M) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Capricorn Scientific, Sartorius, Biowest, Cellseco, Biosera, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Phytohemagglutinin M(PHA-M) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    98% Purity
    99% Purity
    Other
    Market segment by Application
    Research
    Medicine
    Other
    Major players covered
    Capricorn Scientific
    Sartorius
    Biowest
    Cellseco
    Biosera
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Phytohemagglutinin M(PHA-M) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Phytohemagglutinin M(PHA-M), with price, sales quantity, revenue, and global market share of Phytohemagglutinin M(PHA-M) from 2020 to 2025.
    Chapter 3, the Phytohemagglutinin M(PHA-M) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Phytohemagglutinin M(PHA-M) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Phytohemagglutinin M(PHA-M) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Phytohemagglutinin M(PHA-M).
    Chapter 14 and 15, to describe Phytohemagglutinin M(PHA-M) sales channel, distributors, customers, research findings and conclusion.

    Buy now